Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.

about

Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.

Item

http://www.wikidata.org/entity/Q36777530

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.

@ast

Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.

@en

type

Item

label

Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.

@ast

Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.

@en

prefLabel

Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.

@ast

Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.

@en

P1476

Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension

@en

P2093

Abby D Poms

http://www.w3.org/2001/XMLSchema#string

Kishan S Parikh

http://www.w3.org/2001/XMLSchema#string

Terry Fortin

http://www.w3.org/2001/XMLSchema#string

Victor F Tapson

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension

Pulmonary hypertension in chronic lung diseases

Bloodstream infections in patients given treatment with intravenous prostanoids.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs.

Pulmonary hypertension due to left heart diseases.

P304

322-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FJC.0000000000000357

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sudarshan Rajagopal

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26828324

http://www.w3.org/2001/XMLSchema#string

P932

4824653

http://www.w3.org/2001/XMLSchema#string